Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

381 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of SGLT-2 inhibitor use on left ventricular longitudinal strain and NT-proBNP level during six-month follow-up in diabetic patients with and without coronary artery disease with preserved ejection fraction.
Biter HI, Cakal S, Cakal B, Aapaydin Z, Kilinc AY, Oguz H, Yildiz S, Ogur H, Belen E, Simsek E. Biter HI, et al. Among authors: simsek e. Kardiol Pol. 2024 May 20. doi: 10.33963/v.phj.100613. Online ahead of print. Kardiol Pol. 2024. PMID: 38767161 Free article. No abstract available.
Demographic distributions and clinical results of assisted reproduction techniques in Turkey in 2019: a descriptive survey.
Benlioğlu C, Aydın Y, Bahçeci M, Baltacı V, Bulgurcuoğlu S, Demir A, Dilbaz S, Ergin E, Fındıklı N, Göksever Çelik H, Güler İ, Işıkoğlu M, Mümüşoğlu S, Özekinci M, Özörnek H, Şimşek E, Şükür YE, Uncu G, Urman B, Vicdan K, Yaralı H, Balaban B, Ata B. Benlioğlu C, et al. Among authors: simsek e. J Turk Ger Gynecol Assoc. 2024 Mar 6;25(1):18-23. doi: 10.4274/jtgga.galenos.2023.2023-3-12. J Turk Ger Gynecol Assoc. 2024. PMID: 38444322 Free PMC article.
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study.
Yıldırım HÇ, Kutlu Y, Mutlu E, Aykan MB, Korkmaz M, Yalçın S, Şakalar T, Celayir ÖM, Kayıkçıoğlu E, Aslan F, Hafızoğlu E, Altıntaş YE, Keskinkılıç M, Chalabiyev E, Çelebi A, Dursun B, Kapar C, Özen M, Acar Ö, Dülgar Ö, Kut E, Biter S, Kus F, Almuradova E, Erdoğan AP, Saray S, Güven DC, Şimşek ET, Üskent N, Kemal Y, Çakar B, Açıkgöz Ö, Kılıçkap S, Aksoy S. Yıldırım HÇ, et al. Among authors: simsek et. Int J Clin Oncol. 2024 Mar;29(3):258-265. doi: 10.1007/s10147-023-02460-5. Epub 2024 Feb 4. Int J Clin Oncol. 2024. PMID: 38310597
381 results